Table 3.
Characteristics | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
Age (years) | ||||||
< 60.4 | Ref | |||||
≥ 60.4 | 1.19 | 0.80–1.77 | 0.390 | |||
Gender | ||||||
Female | Ref | |||||
Male | 1.12 | 0.75–1.67 | 0.560 | |||
Histology | ||||||
Adenocarcinoma | Ref | |||||
Carcinoma | 0.86 | 0.55–1.35 | 0.510 | |||
Squamous cell carcinoma | 0.80 | 0.40–1.57 | 0.510 | |||
Visceral metastasis | ||||||
No | Ref | Ref | ||||
Yes | 1.8 | 1.19–2.72 | 0.005 | 1.43 | 0.94–2.19 | 0.100 |
Dominant site of metastasis | ||||||
Other | Ref | |||||
Bone | 1.00 | 0.40–2.48 | 0.980 | |||
Visceral | 1.45 | 0.61–3.46 | 0.390 | |||
Lymph node | 0.68 | 0.27–1.67 | 0.400 | |||
CNS | 0.83 | 0.23–2.99 | 0.780 | |||
ECOG Performance Status | ||||||
< 2 | Ref | Ref | ||||
≥ 2 | 2.65 | 1.67–4.20 | < 0.001 | 2.37 | 1.50–3.76 | < 0.001 |
Unknown | 1.96 | 1.15–2.33 | < 0.001 | 1.69 | 0.98–2.90 | 0.060 |
PD-L1 staining* | ||||||
Negative | Ref | Ref | ||||
Positive | 0.35 | 0.20–0.64 | < 0.001 | 0.42 | 0.23–0.76 | 0.0050 |
OS: Overall survival; CNS: Central Nervous System; (*) according to Combined Positive Score and cutoff of 1 (1 up to 80)